Literature DB >> 15643030

Physician recommendations for follow-up of positive fecal occult blood tests.

K Robin Yabroff1, Carrie N Klabunde, Ron Myers, Martin L Brown.   

Abstract

Following a positive fecal occult blood test (FOBT), physician recommendation of complete diagnostic evaluation (CDE) is an important first step to ensure identification and treatment of preinvasive or invasive colorectal cancer. Physicians may not recommend CDE, however, potentially compromising the effectiveness of colorectal cancer screening programs and the quality of care for individual patients. The authors used a theoretical model of health behavior and two national physician samples to explore factors associated with recommendations for CDE. Overall, 63 percent of the sample of physicians providing primary care and 76 percent of the gastroenterologist and general surgeon sample reported recommending CDE. Variables representing the theoretical model constructs of physician background, experience, and practice patterns; practice environment; physician psychosocial representations; and patient characteristics were significantly associated with recommendations of CDE. Development of interventions to improve recommendations of CDE is an important area for future research.

Entities:  

Mesh:

Year:  2005        PMID: 15643030     DOI: 10.1177/1077558704271725

Source DB:  PubMed          Journal:  Med Care Res Rev        ISSN: 1077-5587            Impact factor:   3.929


  10 in total

1.  Use of Tracking and Reminder Systems for Colorectal Cancer Screening in Indian Health Service and Tribal Facilities.

Authors:  J A Craig; Diana Redwood; Ellen Provost; Donald Haverkamp; D K Espey
Journal:  IHS Prim Care Provid       Date:  2015-02

2.  Are physicians' recommendations for colorectal cancer screening guideline-consistent?

Authors:  K Robin Yabroff; Carrie N Klabunde; Gigi Yuan; Timothy S McNeel; Martin L Brown; Dana Casciotti; Dennis W Buckman; Stephen Taplin
Journal:  J Gen Intern Med       Date:  2010-10-14       Impact factor: 5.128

3.  Latinas' Colorectal Cancer Screening Knowledge, Barriers to Receipt, and Feasibility of Home-Based Fecal Immunochemical Testing.

Authors:  Echo L Warner; Julia Bodson; Ryan Mooney; Djin Lai; N Jewel Samadder; Deanna Kepka
Journal:  J Immigr Minor Health       Date:  2018-08

4.  Using a multifaceted approach to improve the follow-up of positive fecal occult blood test results.

Authors:  Hardeep Singh; Himabindu Kadiyala; Gayathri Bhagwath; Anila Shethia; Hashem El-Serag; Annette Walder; Maria E Velez; Laura A Petersen
Journal:  Am J Gastroenterol       Date:  2009-03-17       Impact factor: 10.864

5.  Primary care practice organization influences colorectal cancer screening performance.

Authors:  Elizabeth M Yano; Lynn M Soban; Patricia H Parkerton; David A Etzioni
Journal:  Health Serv Res       Date:  2007-06       Impact factor: 3.402

6.  The effects of teamwork and system support on colorectal cancer screening in primary care practices.

Authors:  Shawna V Hudson; Pamela Ohman-Strickland; Regina Cunningham; Jeanne M Ferrante; Karissa Hahn; Benjamin F Crabtree
Journal:  Cancer Detect Prev       Date:  2007-11-26

7.  Promoting colorectal cancer screening among Haitian Americans.

Authors:  Steven S Coughlin; Erica I Lubetkin; Jennifer L Hay; Renald Raphael; Selina A Smith
Journal:  J Ga Public Health Assoc       Date:  2015

8.  Physician recommendation and patient adherence for colorectal cancer screening.

Authors:  Shawna V Hudson; Jeanne M Ferrante; Pamela Ohman-Strickland; Karissa A Hahn; Eric K Shaw; Jennifer Hemler; Benjamin F Crabtree
Journal:  J Am Board Fam Med       Date:  2012 Nov-Dec       Impact factor: 2.657

9.  Factors associated with intentions to adhere to colorectal cancer screening follow-up exams.

Authors:  Ying-Fang Zheng; Tami Saito; Miyako Takahashi; Teruo Ishibashi; Ichiro Kai
Journal:  BMC Public Health       Date:  2006-11-06       Impact factor: 3.295

10.  A survey of physician receptivity to molecular diagnostic testing and readiness to act on results for early-stage colon cancer patients.

Authors:  Ronald E Myers; Thomas Wolf; Phillip Shwae; Sarah Hegarty; Stephen C Peiper; Scott A Waldman
Journal:  BMC Cancer       Date:  2016-10-03       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.